Form 4 holding
Director
Helus Pharma Inc.
- Security class
- Common Shares
- Shares / value
- 156,000
- Estimated value
- $1,917,240
- Report date
- 13 Oct 2026
- Price
- $12.29
- Ownership
- Held by Greywolf Management Services Inc.
Grant Froese - Director at CYBIN INC.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- HELP on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Grant Froese since 25 Oct 2025
Reported holdings for Grant Froese in CYBIN INC.
Form 4 holding
Director
Helus Pharma Inc.
- Security class
- Common Shares
- Shares / value
- 5,263
- Estimated value
- $64,682
- Report date
- 13 Oct 2026
- Price
- $12.29
- Ownership
- Held by spouse
Transaction history for Grant Froese in CYBIN INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.